In Brief “Cecilie,” statue of a woman with incurable breast cancer, unveiled in Norway June 24, 2022Vol.48 No.25
In Brief Texas Oncology breaks ground on comprehensive cancer center in Beaumont June 24, 2022Vol.48 No.25
Trials & Tribulations Transforming the future of radiation oncology:Three ways collaboration accelerates FLASH radiation therapy research June 24, 2022Vol.48 No.25By Karen J. Kirkby
Clinical Roundup ACS study: Cancer survivors have grown to 18 million in the U.S. June 24, 2022Vol.48 No.25
Clinical Roundup Winship study: COVID-19 vaccines much less effective for patients with NHL/CLL June 24, 2022Vol.48 No.25
Clinical Roundup UTSW researchers develop blood test to predict liver cancer risk June 24, 2022Vol.48 No.25
Clinical Roundup Cedars-Sinai study: Targeting IL-27 signaling pathway may help develop immunotherapies for HCC June 24, 2022Vol.48 No.25
Drugs & Targets FDA grants accelerated approval to Tafinlar + Mekinist in unresectable or metastatic solid tumors with BRAF V600E mutation June 24, 2022Vol.48 No.25
Drugs & Targets FDA grants Fast Track designation to IK-930 in unresectable NF2-deficient mesothelioma June 24, 2022Vol.48 No.25
Drugs & Targets Cullinan Oncology, Taiho Pharmaceuticals complete agreement to develop and commercialize CLN-081/TAS6417 June 24, 2022Vol.48 No.25
